Products Description

The Continuous Glucose Monitor PCBA is a miniaturized, ultra-low-power sensing platform designed for wearable enzymatic biosensor systems. Operating from a single silver-oxide coin cell at 1.5 V, the board consumes just 38 µA in active measurement mode and 2.1 µA in deep sleep, enabling up to 14 days of continuous operation from a 180 mAh battery. At its core, a dedicated potentiostat front-end with a 16-bit delta-sigma ADC measures current signals in the 1 nA to 50 µA range, resolving glucose concentrations from 20 to 450 mg/dL with a linearity error below 2%. An onboard temperature-compensation circuit using a high-accuracy NTC thermistor adjusts for enzyme reaction kinetics across 5°C to 45°C, while a built-in electrochemical impedance spectroscopy (EIS) function performs sensor integrity checks every 30 minutes to detect biofilm formation or electrode fouling. Data is transmitted via a Bluetooth 5.3 LE radio with an integrated PCB antenna, achieving a link budget of -96 dBm for reliable smartphone connectivity. The Continuous Glucose Monitor PCBA also includes a haptic driver for discreet user alerts, a 4 KB non-volatile memory for time-stamped calibration coefficients, and a dedicated input for an external skin-temperature sensor to further refine accuracy. With fail-safe mechanisms like a watchdog timer and brown-out detection, the board ensures data integrity during sensor warm-up and daily calibration cycles. Its compact 18 mm × 12 mm form factor fits within a disposable adhesive patch, while the firmware supports over-the-air parameter updates without removing the device. All components are medically qualified to ISO 13485, with the PCBA undergoing 100% functional testing including simulated interstitial fluid validation before shipment.

PCBA Display

Data Acquisition PCBA Frequency Inverter PCBA Precision Signal Processing Board AI Vision Processing PCB Assembly

Products Adventages

The Continuous Glucose Monitor PCBA offers clinically relevant advantages that directly impact user outcomes and device reliability. Its three-electrode potentiostat architecture with a dedicated guard driver eliminates leakage errors common in single-ended designs, delivering a signal-to-noise ratio of 82 dB at 1 nA input-a critical factor for hypo- and hyperglycemic threshold detection where accuracy deviation stays within ±5% across the entire measuring range. The integrated EIS capability performs real-time membrane integrity checks, automatically flagging sensor degradation 8 hours before signal dropout, thereby reducing false alarms and unnecessary sensor replacements by nearly 40% in clinical wear studies.

Power management sets a new efficiency standard: the board's adaptive sampling algorithm adjusts measurement frequency from once per minute during rapid glucose changes to once per 5 minutes during stable periods, cutting average current draw to 26 µA without compromising data resolution. The built-in charge pump generates a stable 600 mV bias voltage with <0.1% ripple, ensuring consistent enzyme oxidation rates even as the battery drains to 1.0 V. For data integrity, the Continuous Glucose Monitor PCBA features a dual-redundant CRC-protected memory bank that stores up to 8 days of 5-minute readings, preventing data loss during unexpected radio disconnections.

The hardware includes a differential input for skin impedance monitoring, enabling the firmware to reject motion artifacts and capacitive coupling noise from clothing static-a feature that improves first-read accuracy during active periods by 32% compared to prior-generation designs. OEMs benefit from a pre-validated glucose algorithm library and calibration-free factory trimming, which reduces system-level development time by over three months, while the board's pin-compatible variants for both Abbott-style and Dexcom-style sensor connectors allow a single PCBA design to support multiple sensor formats with zero hardware changes.

Manufacturing Process

The assembly flow prioritizes ultra-high reliability for implantable-adjacent wearable electronics. Fabrication starts with a 2-layer flexible–rigid hybrid substrate using polyimide for the flexible tail (where the sensor connector resides) and FR4 for the rigid component area, bonded via a thermally cured adhesive film. All passive components are 0201-sized or smaller, placed by a high-precision chip shooter with ±30 µm accuracy, followed by reflow soldering under a nitrogen atmosphere with a peak temperature of 235°C to prevent oxidation of the gold-plated contact pads. The potentiostat IC and Bluetooth transceiver undergo underfill encapsulation using a capillary-flow epoxy, cured at 80°C for 20 minutes to enhance mechanical shock resistance for drop survival up to 1.5 meters.

After primary soldering, each unit proceeds through a triple-wash cleaning process-saponified aqueous, deionized water rinse, and isopropyl alcohol final-to remove flux residues that could interfere with nA-level current measurements. A plasma activation step then prepares the surface for conformal coating, with a 10 µm parylene-C layer uniformly deposited via chemical vapor deposition, providing both moisture barrier (water vapor transmission <0.5 g/m²/day) and dielectric isolation. Selective laser ablation removes coating from test points and battery contacts without damaging underlying traces.

Electrical calibration occurs in a temperature-controlled chamber at 37°C ±0.5°C, simulating skin-surface conditions, with each board receiving a 32-point gain and offset correction stored in an EEPROM. A 72-hour accelerated life test applies cyclic humidity (20% to 90% RH) and thermal shocks (-5°C to 50°C) while continuously measuring known resistor loads to verify drift below ±0.5%. Finally, every assembly undergoes a 100% functional verification using a glucose-simulating electrochemical cell, with pass/fail criteria set at 98% correlation to a reference benchtop potentiostat. Serialized laser marking and individual test-report generation complete the process, ensuring full traceability from panel to patient-use configuration.

Q&A

Q1: What special handling or cleaning processes do you apply to ensure nA-level current measurement accuracy?**
A: We use a dedicated assembly line with no lead-containing materials or sulfur-bearing compounds. After reflow, boards undergo a three-stage aqueous cleaning with saponifier, followed by deionized rinse and IPA final wash, then baked at 60°C for 2 hours. The entire process takes place in a Class 1000 cleanroom, with operators wearing low-outgassing gloves. We also perform extraction testing on each batch using ion chromatography to verify residual ionic contamination stays below 0.5 µg NaCl equivalent per cm².

Q2: How do you guarantee sensor contact integrity and prevent corrosion over the 14-day wear period?**
A: The flexible tail's gold-plated contact pads receive an additional 0.3 µm of palladium over the ENIG finish, with laser-microscopy verification of pad roughness. We also apply a proprietary anti-tarnish protective layer that is removed only during the final assembly of the sensor connector. Each board undergoes a 48-hour salt-spray test per ISO 9227, followed by contact-resistance measurements before and after, ensuring less than 5 mΩ change over the entire test.

Q3: What calibration support and data traceability do you provide for regulatory submissions?**
A: We deliver a comprehensive calibration certificate for every unit, including individual gain coefficients, offset voltages, and temperature-compensation curve parameters measured across 5°C–45°C in 2°C steps. All test equipment is NIST-traceable with calibration records available upon request. We also supply a full production data package containing X-ray images, solder-profile graphs, and a CPK report for critical parameters. This package is formatted to align with FDA 510(k) and CE marking documentation requirements, streamlining your regulatory compilation process.